Search This Blog

Thursday, October 29, 2026

Insmed revenue beats, raises 2026 BRINSUPRI and ARIKAYCE revenue guidance

 

Insmed Q3 2026 revenue $524.4M (+268% YoY) beats estimates as EPS loss $0.46 misses, raises 2026 BRINSUPRI and ARIKAYCE revenue guidance

  • Insmed reported a sharply reduced Q3 2026 net loss totaling $100.3 million.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)